| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Maciej Jakubowski | Q86775646 |
| Ewa Szahidewicz-Krupska | Q87638192 | ||
| Adrian Doroszko | Q56223819 | ||
| P2860 | cites work | Does warfarin enhance platelet activity? | Q71843061 |
| [Effect of carnosine and its derivatives on ADP-induced human platelet aggregation] | Q72288264 | ||
| Interrelationships among platelet responses: studies on the burst in proton liberation, lactate production, and oxygen uptake during platelet aggregation and Ca2+ secretion | Q72886194 | ||
| Synergistic interaction of adrenaline and histamine in human platelet aggregation is mediated through activation of phospholipase, map kinase and cyclo-oxygenase pathways | Q73053573 | ||
| Paroxetine decreases platelet serotonin storage and platelet function in human beings | Q73148570 | ||
| Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial | Q73423989 | ||
| Effect of anti-carbonic anhydrase antibodies on carbonic anhydrases I and II | Q73552718 | ||
| Enhanced P-selectin expression in chronic and dermographic urticaria | Q73711742 | ||
| Mechanism of epinephrine-induced platelet aggregation | Q74165850 | ||
| [Presence of carbonic anhydrase in human platelets] | Q74493674 | ||
| THE EFFECT OF ACETYLSALICYLIC ACID ON CARBONIC ANHYDRASE IN VITRO | Q76576654 | ||
| Warfarin or acenocoumarol: which is better in the management of oral anticoagulants? | Q77737079 | ||
| Effect of histidine on myocardial mitochondria and platelet aggregation during thrombotic cerebral ischemia in rats | Q77902256 | ||
| Inhibition of platelet aggregation by S-nitroso-cysteine via cGMP-independent mechanisms: evidence of inhibition of thromboxane A2 synthesis in human blood platelets | Q77937629 | ||
| Serotonin is associated with coronary artery disease and cardiac events | Q78077693 | ||
| Increased serum anti-carbonic anhydrase II antibodies in patients with Graves' disease | Q80363119 | ||
| Induction of anti-carbonic-anhydrase-II antibody causes renal tubular acidosis in a mouse model of Sjogren's syndrome | Q80593746 | ||
| Platelet aggregation profile as a marker of hydroxyurea bioavailability through nitric oxide generation in chronic myelogenous leukemia | Q83322880 | ||
| Novel carbonic anhydrase autoantibodies and renal manifestations in patients with primary Sjogren's syndrome | Q83682658 | ||
| Citalopram is a more potent platelet function inhibitor than paroxetine in a case-control study | Q83691654 | ||
| Effects of additional treatment of sarpogrelate to aspirin therapy on platelet aggregation and plasma plasminogen activator inhibitor activity in patients with stable effort angina | Q84489704 | ||
| The effect of acenocoumarol on the antiplatelet effect of clopidogrel | Q85602424 | ||
| Exertional rhabdomyolysis in carbonic anhydrase 12 deficiency | Q88640512 | ||
| Carbonic anhydrases are producers of S-nitrosothiols from inorganic nitrite and modulators of soluble guanylyl cyclase in human platelets | Q89337303 | ||
| Non-Classical Inhibition of Carbonic Anhydrase | Q26738744 | ||
| Nuclear receptors in bone physiology and diseases | Q26853017 | ||
| Crystallographic studies of the binding of protonated and unprotonated inhibitors to carbonic anhydrase using hydrogen sulphide and nitrate anions | Q27642096 | ||
| Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition | Q27643006 | ||
| Structure and metal exchange in the cadmium carbonic anhydrase of marine diatoms | Q27650001 | ||
| Carbonic anhydrase inhibitors. Interaction of indapamide and related diuretics with 12 mammalian isozymes and X-ray crystallographic studies for the indapamide-isozyme II adduct | Q27650185 | ||
| Discovery of a new family of carbonic anhydrases in the malaria pathogen Plasmodium falciparum--the η-carbonic anhydrases | Q27973368 | ||
| Structure and mechanism of carbonic anhydrase | Q28111928 | ||
| Erythrocyte Carbonic Anhydrase I: Inherited Deficiency in Humans | Q28236214 | ||
| Carbonic anhydrases: novel therapeutic applications for inhibitors and activators | Q28263238 | ||
| The gene for human carbonic anhydrase II (CA2) is located at chromosome 8q22 | Q28290513 | ||
| Carbonic anhydrase inhibitors and high altitude illnesses | Q28300691 | ||
| Carbonic anhydrase II deficiency in 12 families with the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification | Q28307228 | ||
| Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction | Q28345555 | ||
| Metabolic transformation of neuropeptide carnosine modifies its biological activity | Q28371780 | ||
| Platelet inhibition by nitrite is dependent on erythrocytes and deoxygenation | Q28732676 | ||
| A new target for autoantibodies in patients with rheumatoid arthritis | Q33300254 | ||
| Carbonic anhydrase III is insufficient in muscles of myasthenia gravis patients | Q33419952 | ||
| Sodium-hydrogen exchange and platelet function | Q33730450 | ||
| Detection of autoantibodies against carbonic anhydrase I and II in the plasma of patients with gastric cancer | Q33797159 | ||
| Acetazolamide in the treatment of seizures | Q34391022 | ||
| Expression of monocarboxylate transporter 4 in human platelets, leukocytes, and tissues assessed by antibodies raised against terminal versus pre-terminal peptides | Q34483060 | ||
| Effect of blood nitrite and nitrate levels on murine platelet function | Q34577209 | ||
| Pharmacotherapy of glaucoma | Q35138049 | ||
| A phenocopy of CAII deficiency: a novel genetic explanation for inherited infantile osteopetrosis with distal renal tubular acidosis | Q35441615 | ||
| The effect of acetazolamide on sleep apnea at high altitude: a systematic review and meta-analysis. | Q36237460 | ||
| Carbonic anhydrases as targets for medicinal chemistry | Q36809436 | ||
| Carbonic anhydrase activation and the drug design | Q37108543 | ||
| Thylakoid luminal θ-carbonic anhydrase critical for growth and photosynthesis in the marine diatom Phaeodactylum tricornutum | Q37258444 | ||
| Platelets at work in primary hemostasis. | Q37865759 | ||
| Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms? | Q38011235 | ||
| Platelet count, platelet aggregation and fibrinogen levels following acute induction to high altitude (3200 and 3771 metres) | Q57128762 | ||
| Platelet activation in chronic urticaria and its correlation with disease severity | Q58623310 | ||
| Mono- and di-halogenated histamine, histidine and carnosine derivatives are potent carbonic anhydrase I, II, VII, XII and XIV activators | Q58863173 | ||
| Carbonic anhydrase activators: l-Adrenaline plugs the active site entrance of isozyme II, activating better isoforms I, IV, VA, VII, and XIV | Q58863253 | ||
| Inhibition of ADP-induced Platelet Aggregation by Substituted Amino-acids | Q59094272 | ||
| A role for intracellular histamine in collagen-induced platelet aggregation | Q67266945 | ||
| Inhibition of the platelet release reaction and platelet prostagland in synthesis by furosemide | Q67446602 | ||
| Furosemide: its role on certain platelet functions | Q67668514 | ||
| Abnormal platelet aggregation associated with fluoxetine therapy | Q67987603 | ||
| A novel autoantibody reactive with carbonic anhydrase in sera from patients with systemic lupus erythematosus and Sjögren's syndrome | Q67996034 | ||
| The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium | Q69813452 | ||
| Effect of L-histidine in vivo on human platelet function and arachidonic acid metabolism | Q69951770 | ||
| Histamine is an intracellular messenger mediating platelet aggregation | Q69971409 | ||
| Correlation of plasma serotonin changes with platelet aggregation in an in vivo dog model of spontaneous occlusive coronary thrombus formation | Q69994565 | ||
| The effect of carbonic anhydrase inhibition on the velocity of thrombin-stimulated platelet aggregation under physiological conditions | Q70483379 | ||
| Carbonic anhydrase in human platelets: effects of carbonic anhydrase inhibition on platelet aggregation | Q70487893 | ||
| Nonsteroidal anti-inflammatory drugs activate carbonic anhydrase by a direct mechanism of action | Q71152709 | ||
| Demonstration of histamine receptors on human platelets by flow cytometry | Q71282758 | ||
| Indapamide inhibits human platelet aggregation in vitro: comparison with hydrochlorothiazide | Q71608788 | ||
| Structure, function and applications of carbonic anhydrase isozymes | Q38011307 | ||
| Osteopetrosis: genetics, treatment and new insights into osteoclast function. | Q38123371 | ||
| Effects of thiazide-type and thiazide-like diuretics on cardiovascular events and mortality: systematic review and meta-analysis. | Q38367051 | ||
| A review and discussion of platelet nitric oxide and nitric oxide synthase: do blood platelets produce nitric oxide from L-arginine or nitrite? | Q38451947 | ||
| Acetazolamide for the treatment of idiopathic intracranial hypertension | Q38543994 | ||
| Dual Cyclooxygenase and Carbonic Anhydrase Inhibition by Nonsteroidal Anti-Inflammatory Drugs for the Treatment of Cancer | Q38548189 | ||
| Cocoa: a new mouse model for platelet storage pool deficiency | Q38594261 | ||
| How many carbonic anhydrase inhibition mechanisms exist? | Q38653464 | ||
| Simultaneous measurement of aggregation, secretion, oxygen uptake, proton production, and intracellular metabolites in the same platelet suspension | Q39295930 | ||
| Autoimmunity against carbonic anhydrase II affects retinal cell functions in autoimmune retinopathy | Q39875824 | ||
| PATHOLOGIC FEATURES OF ALTITUDE SICKNESS | Q41814670 | ||
| Carbonic anhydrase in human platelets | Q41827894 | ||
| Platelet Carbonic Anhydrase II, a Forgotten Enzyme, May Be Responsible for Aspirin Resistance. | Q42706087 | ||
| Anti-carbonic anhydrase II antibodies in end-stage renal disease patients | Q42759354 | ||
| Chlorthalidone decreases platelet aggregation and vascular permeability and promotes angiogenesis | Q42972405 | ||
| Nitric oxide-sensitive guanylyl cyclase is the only nitric oxide receptor mediating platelet inhibition | Q43165390 | ||
| Generation of nitric oxide from nitrite by carbonic anhydrase: a possible link between metabolic activity and vasodilation | Q43263730 | ||
| Effect of prolonged stay at high altitude on platelet aggregation and fibrinogen levels | Q43297938 | ||
| Helicobacter pylori and autoimmune pancreatitis: role of carbonic anhydrase via molecular mimicry? | Q43501527 | ||
| Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors | Q43631761 | ||
| Indomethacin activates carbonic anhydrase and antagonizes the effect of the specific carbonic anhydrase inhibitor acetazolamide, by a direct mechanism of action | Q43656670 | ||
| Chloride increases adrenergic receptor-mediated platelet and vascular responses | Q44034792 | ||
| Platelet adhesiveness on acute induction to high altitude | Q44242793 | ||
| Carbonic anhydrase inhibition by flurbiprofen and related agents | Q44353569 | ||
| Hydroxyurea is a carbonic anhydrase inhibitor | Q44416611 | ||
| Carbonic anhydrase activators. The selective serotonin reuptake inhibitors fluoxetine, sertraline and citalopram are strong activators of isozymes I and II. | Q44520584 | ||
| In vitro inhibition of salicylic acid derivatives on human cytosolic carbonic anhydrase isozymes I and II. | Q46344756 | ||
| Glucose uptake via glucose transporter 3 by human platelets is regulated by protein kinase B. | Q46622425 | ||
| Discovery and microassay of a nitrite-dependent carbonic anhydrase activity by stable-isotope dilution gas chromatography-mass spectrometry | Q46675324 | ||
| Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II "selective" inhibitor celecoxib | Q46806150 | ||
| Inhibition of 5-hydroxytryptamine receptor prevents occlusive thrombus formation on neointima of the rabbit femoral artery | Q46892256 | ||
| Suppression of adjuvant-induced arthritic bone destruction by cyclooxygenase-2 selective agents with and without inhibitory potency against carbonic anhydrase II. | Q46898242 | ||
| Parallel ocular and serologic course in a patient with early Sjogren's syndrome markers | Q47110714 | ||
| Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors Are Not Associated With Bleeding or Transfusion in Cardiac Surgical Patients | Q47223726 | ||
| Suppression of CHRN endocytosis by carbonic anhydrase CAR3 in the pathogenesis of myasthenia gravis | Q47768895 | ||
| Novel carbonic anhydrase IX-targeted therapy enhances the anti-tumour effects of cisplatin in small cell lung cancer. | Q47804424 | ||
| The role of histamine in platelet aggregation by physiological and immunological stimuli | Q47872386 | ||
| Autoantibodies Against Carbonic Anhydrase I and II in Patients with Acute Myeloid Leukemia. | Q47965507 | ||
| Effect of sarpogrelate, a 5-HT(2A) antagonist, on platelet aggregation in patients with ischemic stroke: clinical-pharmacological dose-response study | Q48109716 | ||
| Defective hepatic bicarbonate production due to carbonic anhydrase VA deficiency leads to early-onset life-threatening metabolic crisis. | Q48229975 | ||
| S-nitrosocysteine inhibition of human platelet secretion is correlated with increases in platelet cGMP levels | Q50803698 | ||
| Carbonic anhydrase I and II autoantibodies in Behçet's disease. | Q51003756 | ||
| Hyperreactive platelet phenotypes: relationship to altered serotonin transporter number, transport kinetics and intrinsic response to adrenergic co-stimulation. | Q51290210 | ||
| Utility of Novel Autoantibodies in the Diagnosis of Sjögren's Syndrome Among Patients With Dry Eye. | Q52674211 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P921 | main subject | platelet | Q101026 |
| P304 | page(s) | 4548353 | |
| P577 | publication date | 2018-06-28 | |
| P1433 | published in | BioMed Research International | Q17509958 |
| P1476 | title | The Human Carbonic Anhydrase II in Platelets: An Underestimated Field of Its Activity | |
| P478 | volume | 2018 |
| Q64983144 | Carbonic Anhydrases in Photosynthesizing Cells of C3 Higher Plants. | cites work | P2860 |
Search more.